63.69MMarket Cap-1.20P/E (TTM)
4.870High4.610Low37.07KVolume4.840Open4.780Pre Close178.13KTurnover0.89%Turnover RatioLossP/E (Static)13.44MShares19.99952wk High0.61P/B19.83MFloat Cap4.45052wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM5.44%Amplitude4.450Historical Low4.805Avg Price1Lot Size
OnKure Therapeutics Stock Forum
OnKure Q4 Earnings: $110.8M Cash Position Powers Clinical Trial Progress
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet